B.J. Riis

2.5k total citations · 1 hit paper
40 papers, 1.9k citations indexed

About

B.J. Riis is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, B.J. Riis has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology and Allergy, 11 papers in Physiology and 8 papers in Dermatology. Recurrent topics in B.J. Riis's work include Allergic Rhinitis and Sensitization (15 papers), Asthma and respiratory diseases (10 papers) and Dermatology and Skin Diseases (7 papers). B.J. Riis is often cited by papers focused on Allergic Rhinitis and Sensitization (15 papers), Asthma and respiratory diseases (10 papers) and Dermatology and Skin Diseases (7 papers). B.J. Riis collaborates with scholars based in Denmark, United States and Germany. B.J. Riis's co-authors include Stephen R. Durham, W. Emminger, Alexander Kapp, Ronald Dahl, S. Rak, Jan G.R. de Monchy, Claus Christiansen, Jens Andersen, Glenis Scadding and M.A. Karsdal and has published in prestigious journals such as JAMA, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

B.J. Riis

39 papers receiving 1.8k citations

Hit Papers

SQ-standardized sublingual grass immunotherapy: Confirmat... 2012 2026 2016 2021 2012 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
    2012 376 citations Stephen R. Durham, W. Emminger et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.J. Riis Denmark 17 1.2k 1.2k 650 237 196 40 1.9k
Anita Remitz Finland 20 606 0.5× 224 0.2× 886 1.4× 30 0.1× 158 0.8× 48 1.3k
Megumi Kishimoto Japan 15 78 0.1× 217 0.2× 386 0.6× 52 0.2× 168 0.9× 38 1.1k
Rosa Muñoz‐Cano Spain 19 799 0.6× 488 0.4× 358 0.6× 90 0.4× 128 0.7× 78 1.3k
Lawrence B. Schwartz United States 14 722 0.6× 581 0.5× 130 0.2× 201 0.8× 112 0.6× 14 1.4k
Kristensen Jk Denmark 13 43 0.0× 206 0.2× 145 0.2× 52 0.2× 81 0.4× 62 714
R. M. Watson Canada 17 405 0.3× 966 0.8× 44 0.1× 541 2.3× 118 0.6× 20 1.2k
Weiguo Yao United States 16 247 0.2× 408 0.3× 236 0.4× 101 0.4× 180 0.9× 34 1.3k
Claudio Mastruzzo Italy 18 195 0.2× 327 0.3× 76 0.1× 339 1.4× 196 1.0× 29 874
Janet H. Prystowsky United States 18 62 0.1× 141 0.1× 666 1.0× 37 0.2× 263 1.3× 38 1.3k
Frances Lawlor United Kingdom 17 264 0.2× 90 0.1× 470 0.7× 16 0.1× 70 0.4× 41 1.4k

Countries citing papers authored by B.J. Riis

Since Specialization
Citations

This map shows the geographic impact of B.J. Riis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.J. Riis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.J. Riis more than expected).

Fields of papers citing papers by B.J. Riis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.J. Riis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.J. Riis. The network helps show where B.J. Riis may publish in the future.

Co-authorship network of co-authors of B.J. Riis

This figure shows the co-authorship network connecting the top 25 collaborators of B.J. Riis. A scholar is included among the top collaborators of B.J. Riis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.J. Riis. B.J. Riis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bay‐Jensen, Anne‐Christine, M.A. Karsdal, I. Byrjalsen, et al.. (2019). Biomarkers of bone and cartilage turnover CTX-I and CTX-II predict total joint replacements in osteoarthritis. Osteoarthritis and Cartilage. 27. S31–S32. 6 indexed citations
2.
Eriksson, Göran, Hendrik Nolte, Christian Ljørring, B.J. Riis, & J. Christian Virchow. (2019). Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial. Respiratory Medicine. 153. 1–2.
3.
Bay‐Jensen, Anne‐Christine, I. Byrjalsen, Asger Reinstrup Bihlet, et al.. (2015). Segregating OA patients with and without joint inflammation using two biomarkers of connective tissue inflammation. Osteoarthritis and Cartilage. 23. A88–A89. 1 indexed citations
4.
Karsdal, M.A., I. Byrjalsen, Peter Alexandersen, et al.. (2015). Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials. Osteoarthritis and Cartilage. 23(4). 532–543. 101 indexed citations
5.
Backer, Vibeke, et al.. (2014). HDM sublingual AIT tablet is well-tolerated and effective in partly and uncontrolled allergic asthma. European Respiratory Journal. 44(Suppl 58). P298–P298. 3 indexed citations
6.
Blay, F. de, Piotr Kuna, Luis Prieto, et al.. (2014). SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial. Respiratory Medicine. 108(10). 1430–1437. 54 indexed citations
7.
8.
Durham, Stephen R., W. Emminger, Alexander Kapp, et al.. (2012). SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. Journal of Allergy and Clinical Immunology. 129(3). 717–725.e5. 376 indexed citations breakdown →
9.
Durham, Stephen R., W. Emminger, Alexander Kapp, et al.. (2010). Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. Journal of Allergy and Clinical Immunology. 125(1). 131–138.e7. 262 indexed citations
10.
Leeming, D.J., Dorthe Vang Larsen, Sanne Skovgård Veidal, et al.. (2010). Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP) — Assessment of corresponding epitopes. Clinical Biochemistry. 43(15). 1249–1256. 54 indexed citations
11.
Karsdal, M.A., Kim Henriksen, Anne‐Christine Bay‐Jensen, et al.. (2010). Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials. The Journal of Clinical Pharmacology. 51(4). 460–471. 77 indexed citations
12.
Durham, Stephen R., Ronald Dahl, Alexander Kapp, et al.. (2009). Sustained, disease-modifying effect of grass allergen tablet immunotherapy 1 year after completion of treatment. Data Archiving and Networked Services (DANS). 3 indexed citations
13.
Karsdal, M.A., I. Byrjalsen, M. Azria, et al.. (2009). Influence of food intake on the bioavailability and efficacy of oral calcitonin. British Journal of Clinical Pharmacology. 67(4). 413–420. 33 indexed citations
14.
15.
Dahl, Ronald, Alexander Kapp, Giselda Colombo, et al.. (2008). Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. Journal of Allergy and Clinical Immunology. 121(2). 512–518.e2. 160 indexed citations
16.
Durham, Stephen R. & B.J. Riis. (2007). Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy. 62(8). 954–957. 49 indexed citations
17.
Juniper, Elizabeth F., B.J. Riis, & Bridget Juniper. (2007). Development and validation of an electronic version of the Rhinoconjunctivitis Quality of Life Questionnaire. Allergy. 62(9). 1091–1093. 33 indexed citations
18.
Karsdal, M.A., László B. Tankó, B.J. Riis, et al.. (2006). Calcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA?. Osteoarthritis and Cartilage. 14(7). 617–624. 48 indexed citations
19.
Reginster, Jean‐Yves, L. Bufalino, Claus Christiansen, et al.. (1997). Design for an ipriflavone multicenter European fracture study. Calcified Tissue International. 61(S1). S28–S32. 5 indexed citations
20.
Riis, B.J.. (1994). Premenopausal bone loss: Fact or artifact?. Osteoporosis International. 4(S1). S35–S37. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anita Remitz Breakdown of academic impact, for papers by Megumi Kishimoto Breakdown of academic impact, for papers by Rosa Muñoz‐Cano Breakdown of academic impact, for papers by Lawrence B. Schwartz Breakdown of academic impact, for papers by Kristensen Jk Breakdown of academic impact, for papers by R. M. Watson Breakdown of academic impact, for papers by Weiguo Yao Breakdown of academic impact, for papers by Claudio Mastruzzo Breakdown of academic impact, for papers by Janet H. Prystowsky Breakdown of academic impact, for papers by Frances Lawlor
Rankless by CCL
2026